A.M.L. v. Department of Health, Division of Health Care Financing

863 P.2d 44, 224 Utah Adv. Rep. 26, 1993 Utah App. LEXIS 175, 1993 WL 430488
CourtCourt of Appeals of Utah
DecidedOctober 21, 1993
Docket920595-CA
StatusPublished
Cited by7 cases

This text of 863 P.2d 44 (A.M.L. v. Department of Health, Division of Health Care Financing) is published on Counsel Stack Legal Research, covering Court of Appeals of Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
A.M.L. v. Department of Health, Division of Health Care Financing, 863 P.2d 44, 224 Utah Adv. Rep. 26, 1993 Utah App. LEXIS 175, 1993 WL 430488 (Utah Ct. App. 1993).

Opinion

GREENWOOD, Judge:

A.M.L. petitions for review of a final decision of the Division of Health Care Financing (DHCF) denying her Medicaid benefits for a reduction mammaplasty (breast reduction) that DHCF deemed “medically unnecessary” in her case. We reverse.

FACTS

A.M.L. is a twenty-eight year old woman who has had systemic lupus erythematosus (lupus) since she was eighteen years old. Lupus is a chronic, inflammatory disease in which the body’s immune system forms antibodies that attack healthy tissues and organs. It can affect any body organ or system, such as the blood, skin, joints, kidneys, brain, heart, lungs, central nervous system, or connective tissue. Lupus is presently incurable.

To slow the progress of the disease, A.M.L.’s primary physician, Dr. David C. Flinders, prescribed the drug Prednisone, a corticosteroid. This anti-inflammatory drug has been widely used to manage lupus despite its several potentially serious side effects. Among these side effects are appetite stimulation, water retention, and weight gain. A.M.L. has gained sixty-six pounds since she started taking Predni-sone.

A disproportionate amount of A.M.L.’s weight gain occurred in her breasts — her bra size increased from a 36B to a 44DD. Dr. Flinders attributes this weight gain distribution to the fact that steroid use can cause truncal obesity. As a result of the substantial increase in A.M.L.’s breast size, she experiences chronic neck and back problems, numbness in her arms and hands, headaches, and difficulty in breathing. In addition, she has painful grooves in her shoulders from her bra straps, extremely sensitive stretch marks one to two inches wide, 1 and in the summer she suffers from severe yeast infections and sores under her breasts.

Because A.M.L. was in continual pain due to her large breasts, she sought a referral from her treating physician for a reduction mammaplasty. Dr. Charles Pledger, a plastic surgeon, agreed with Dr. Flinders that A.M.L. would benefit from this procedure because A.M.L. has about 800 to 1000 grams of excess tissue in each breast. 2 In the opinion of both Dr. Pledger and Dr. Flinders, A.M.L.’s requested breast reduction would not be for cosmetic reasons, but rather for medical reasons, including relief of pain.

*46 On March 15, 1991, Dr. Pledger filed on behalf of A.M.L. a Request for Prior Authorization for a reduction mammaplasty. DHCF denied this request on April 10, 1991. A.M.L. requested, and received, a formal administrative hearing which was held on August 9, 1991. Following the hearing, the hearing officer recommended that A.M.L.’s request for prior authorization be denied, reasoning that her case did not fit among the listed exceptions to the genera] rule barring cosmetic, plastic, or reconstructive services. 3 He did comment, however, that A.M.L. had presented a compelling case for an exception tó this rule.

Rod Betit, Interim Executive Director of the Department of Health, reviewed the hearing officer’s recommended decision and remanded the case to obtain recommendations from a DHCF physician regarding the “medical necessity” of the breast reduction and to determine whether an exception to current policy should be made in A.M.L.’s case. Pursuant to the remand, the hearing officer requested that Dr. John C. Hylen, a DHCF physician who is board certified in internal medicine, review the matter and provide an opinion.

Dr. Hylen subsequently submitted a written statement indicating that the breast reduction requested by A.M.L. was not “medically necessary.” Dr. Hylen did not personally examine A.M.L. However, after review of her medical file and Goodman & Gilson, The Pharmacological Basis of Therapeutics 1478-79 (MacMillan 1985), Dr. Hylen opined that Prednisone use, not the large size of A.M.L.’s breasts, caused the yeast infections and sores in the summer. In addition, Dr. Hylen stated that any back pain or curvature of the spine experienced by A.M.L. was probably also due to the Prednisone. He noted that “[e]nlarged breast [sic] complicating pred-nisone therapy causing back pain is rarely reported.”

Thereafter, the hearing officer presided over a second hearing in order to allow A.M.L. to cross examine Dr. Hylen. The hearing officer then filed a Recommended Decision on Remand on July 29, 1992, again denying A.M.L.’s request for preauthorization for reduction mammaplasty. On August 10, 1992, Betit filed a Final Agency Action finding that a breast reduction was of “unproven value” to A.M.L., and that A.M.L. had failed to show, by a preponderance of the evidence, that the procedure was “medically necessary.” A.M.L. seeks review of this determination, arguing that the evidence overwhelmingly supports her position that breast reduction surgery is medically necessary in her case. 4

STANDARD OF REVIEW

Administrative agency action based on factual findings will be overturned only if it “ ‘is not supported by substantial evidence when viewed in light of the whole record before the court.’ ” King v. Industrial Comm’n, 850 P.2d 1281, 1285 (Utah App.1993) (citing Utah Code Ann. § 63-46b-16(4)(g) (1989)). Substantial evidence is defined as “that which a reasonable person ‘might accept as adequate to support a conclusion.’ ” Id. (citations omitted). When reviewing the sub-stantiality of the evidence, the reviewing court must consider both the evidence sup *47 porting the agency’s findings and the evidence negating these findings. First Nat’l Bank of Boston v. County Bd. of Equalization, 799 P.2d 1163, 1165 (Utah 1990). “ ‘Evidence is not substantial “if it is overwhelmed by other evidence — particularly certain types of evidence (e.g., that offered by treating physicians) or if it really constitutes not evidence but mere conclusion.” ’ ” Frey v. Bowen, 816 F.2d 508, 512 (10th Cir.1987) (citations omitted).

ANALYSIS

Medicaid was established in 1965 “for the purpose of providing federal financial assistance to States that choose to reimburse certain costs of medical treatment for needy persons.” Harris v. McRae, 448 U.S. 297, 301, 100 S.Ct. 2671, 2680, 65 L.Ed.2d 784 (1980). The federal government reimburses states electing to participate in the Medicaid program for a percentage of the funds they expend in providing medical care for eligible individuals and families. Allen v. Utah Dep’t of Health, 829 P.2d 122, 124 (Utah App.1992), aff'd,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bacon v. Ohio Dept. of Medicaid
2021 Ohio 4537 (Ohio Court of Appeals, 2021)
Intermountain Healthcare v. OptumHealth
2015 UT App 284 (Court of Appeals of Utah, 2015)
Conley v. Department of Health, Division of Health Financing
2012 UT App 274 (Court of Appeals of Utah, 2012)
Holman v. Ohio Department of Human Services
757 N.E.2d 382 (Ohio Court of Appeals, 2001)
Lucas v. Murray City Civil Service Commission
949 P.2d 746 (Court of Appeals of Utah, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
863 P.2d 44, 224 Utah Adv. Rep. 26, 1993 Utah App. LEXIS 175, 1993 WL 430488, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aml-v-department-of-health-division-of-health-care-financing-utahctapp-1993.